Aktie A3CWG9 GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Aktien

A3CWG9

TREGENL00024

GENIL

Markt geschlossen - Borsa Istanbul
Andere Börsenplätze
 17:09:12 21.05.2024 		% 5 Tage % 1. Jan.
62.4 TRY -3.26% Intraday Chart für Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi +11.63% +33.11%
06.04. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi meldet Ergebniszahlen für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(IBSE:GENIL) added to FTSE All-World Index
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2021
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(IBSE:GENIL) added to S&P Global BMI Index
RS Research announced that it has received TRY 12 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, One Life Ventures GmbH, and other investor
Galventa announced that it has received €0.696 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
ARIAD Pharmaceuticals, Inc Announces Commercial Distribution Agreement with Gen Ilac for Iclusig(Ponatinib) in Turkey
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CWG9 Aktie
  4. Nachrichten Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
  5. Andere Sprachen